Profile: Alba Therapeutics Corporation is a clinical-stage biopharmaceutical company. We focus on the discovery, development and supply of pharmaceutical products to treat autoimmune & inflammatory diseases. Our therapeutic approach includes regulation of intestinal tight junctions to prevent the overexposure of antigens and the consequential inflammatory cascade clinically presented in Crohn's patients. We develop AT-3227 drug candidate and its analogs that show effectiveness in promoting the delivery of a wide variety of drugs & vaccines via nasal, pulmonary, oral & systemic administration.